At a glance
- Originator Organon
- Class Anxiolytics; Nootropics; Pyridines; Small molecules; Thiazoles
- Mechanism of Action 5-HT1A serotonin receptor antagonists; Alpha 2 adrenergic receptor antagonists; Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Cognition disorders; Major depressive disorder
Most Recent Events
- 08 Jan 2001 Discontinued-Preclinical for Anxiety disorders in Netherlands (Unknown route)
- 08 Jan 2001 Discontinued-Preclinical for Cognition disorders in Netherlands (Unknown route)
- 08 Jan 2001 Discontinued-Preclinical for Depression in Netherlands (Unknown route)